MTAC vs THAR
Comparison between MedTech Acquisition Corp - Class A (MTAC, Company) and Tharimmune Inc (THAR, Company).
MTAC vs THAR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
MTAC
$183M
THAR
$183M
Max Drawdown
Winner
MTAC
13.92%
THAR
99.93%
Sharpe Ratio
MTAC
0.44
Winner
THAR
0.90
Industry
MTAC
N/A
THAR
Biotechnology
P/E Ratio
Winner
MTAC
-32.94
THAR
-1.86
PEG Ratio
MTAC
N/A
THAR
-0.01
Debt to Equity
MTAC
0.00%
THAR
0.00%
Free Cash Flow Yield
MTAC
-27.91%
Winner
THAR
-11.52%
P/S Ratio
MTAC
12.43
THAR
N/A
P/B Ratio
MTAC
-12.13
THAR
N/A
MTAC vs THAR - Historical Returns
Returns include dividend reinvestment.
1M
Winner
MTAC
+7.90%
THAR
-26.63%
3M
Winner
MTAC
+9.99%
THAR
-53.89%
6M
Winner
MTAC
+11.55%
THAR
+0.00%
1Y
MTAC
+14.55%
Winner
THAR
+60.14%
5Y(CAGR)
MTAC
N/A
THAR
-76.28%
Max(CAGR)
Winner
MTAC
+3.05%
THAR
-76.28%
MTAC vs THAR - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | MTAC | THAR |
|---|---|---|
| 2026 | N/A | -29.88% |
| 2025 | N/A | +47.80% |
| 2024 | N/A | -73.20% |
| 2023 | +12.84% | -94.03% |
| 2022 | +0.80% | -88.80% |
| 2021 | -6.08% | N/A |
MTAC vs THAR Drawdown Comparison
The maximum drawdown for MTAC was -13.92%, occurring on Mar 7, 2022. Recovery took 622 trading sessions.
The maximum drawdown for THAR was -99.93%, occurring on Apr 9, 2025. This drawdown has not yet recovered.
The current THAR drawdown is -99.85%.
| Rank | MTAC | THAR |
|---|---|---|
| #1 | -13.92% Feb 19, 2021 - Aug 10, 2023 | -99.93% Feb 2, 2022 - Apr 9, 2025 |
| #2 | -1.90% Feb 8, 2021 - Feb 16, 2021 | -26.15% Jan 12, 2022 - Jan 24, 2022 |
| #3 | N/A | -2.13% Jan 24, 2022 - Jan 27, 2022 |
| #4 | N/A | -1.87% Jan 31, 2022 - Feb 2, 2022 |
Correlation
Correlation between MTAC and THAR is -0.37 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.
-0.37
-101
Select Stocks to Compare
Popular: MTAC vs SPYTHAR vs SPY
More Comparisons
Compare with similar stocks